about
Avian Influenza Viruses, Inflammation, and CD8(+) T Cell ImmunityCross-reactive CD8 + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A virusesCrystal structure of theLeishmania majorMIX protein: A scaffold protein that mediates protein-protein interactionsFishing for anti-leishmania drugs: principles and problems.A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell ResponsesSuppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1.Discovery of inhibitors of lupin diadenosine 5',5'''-P(1),P(4)-tetraphosphate hydrolase by virtual screening.Inhibitors of Leishmania GDP-mannose pyrophosphorylase identified by high-throughput screening of small-molecule chemical libraryFine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing.The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii.Oral immunization with a recombinant malaria protein induces conformational antibodies and protects mice against lethal malariaSuppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection.Stability and toxicity of heteroleptic organometallic Bi(V) complexes towards Leishmania major.Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses.Leishmania vaccines: progress and problems.Leishmaniasis: current treatment and prospects for new drugs and vaccines.Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signalingImmune responses during cutaneous and visceral leishmaniasis.Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania.Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses.Bismuth(III) α-hydroxy carboxylates: highly selective toxicity of glycolates towards Leishmania major.SOCS4 is dispensable for an efficient recall response to influenza despite being required for primary immunity.Phylogenetic analysis of the genus Plasmodium based on the gene encoding adenylosuccinate lyase.Early CD44(hi)CD4+ and CD44(hi)CD8+ T cell numbers and the absence of mannose-rich glycoconjugates determine the protective outcome of anti-leishmanial immunity.Characterization of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii.Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii.The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol.Decreased IL-10 and IL-13 production and increased CD44hi T cell recruitment contribute to Leishmania major immunity induced by non-persistent parasites.Diversity and clonotypic composition of influenza-specific CD8+ TCR repertoires remain unaltered in the absence of Aire.Structure of Leishmania mexicana Phosphomannomutase Highlights Similarities with Human IsoformsHomoleptic and Heteroleptic Bismuth(III) Thiazole-Thiolates and the Influence of Ring Substitution on Their Antibacterial and Antileishmanial ActivityStability and toxicity of tris-tolyl bismuth(v) dicarboxylates and their biological activity towards Leishmania majorAnti-leishmanial activity of heteroleptic organometallic Sb(v) compoundsAnti-Leishmanial Activity of Novel Homo- and Heteroleptic Bismuth(iii) ThiocarboxylatesAnti-Leishmanial activity of homo- and heteroleptic bismuth(III) carboxylatesInfluence of glycosylphosphatidylinositol anchorage on the efficacy of DNA vaccines encoding Plasmodium yoelii merozoite surface protein 4/5
P50
Q26765927-CF4F8A2A-23ED-4005-86ED-F690800FC548Q27663289-7D3FA54B-F397-4149-A633-C142C0037D00Q27667434-1B39F53C-DECC-4502-8390-D3F4DDA346B2Q30368435-1CEEFBEA-281E-4674-AB76-72914E5CEFA8Q30388522-4E6284FF-D15E-439E-87FF-A405A3978FD8Q31130829-39EC5724-5770-4C13-8B68-1631B5FE029AQ33482334-08F0DA32-3EB1-43A4-BC81-230ECD755B95Q33531622-7201F30E-0554-4D84-8F73-64FDFA6E0E05Q33877106-A18C21C1-1BAD-4124-B3FD-9C596F14275AQ34026690-D454765E-419F-47C7-8DB1-AD03AF4157E0Q34258733-73351948-6CEA-4F17-A487-FA0BA766F8A9Q34933206-9B13474E-086D-4870-A912-8FC9DA0E001DQ35165316-F6732B04-FA1E-4759-958A-D93F603815B5Q35206275-195A6E9D-2880-4005-AD70-01DEEC7E9A4FQ35845737-C502A449-A762-4F1F-94C1-A1099DCD1B0FQ36726750-F049F396-EF89-41C5-A579-A13085255E6DQ37387410-8D7D5918-1308-41D8-B8BF-D4AC23CE548CQ37523619-81207F47-AECC-45C4-B48E-4A55F5E706FFQ37705621-898FA9D0-2283-4F0C-8BE5-650E0434C3DFQ38235268-BED83C43-D9F6-4925-9A62-90041C77202EQ39067074-18F303E8-A85F-4FB9-88C7-D77FC51CFA94Q40184427-25E1EF0C-2A30-4899-A8B9-AAA82A52BB1AQ40429852-10663A02-7249-4A0B-905D-B198DE2CED17Q40494760-6D61505A-5526-4EBE-B32E-FCDD71267B42Q40832857-A028DD90-CF92-4E50-943F-1CB73F08FF86Q44472369-05CB8FB8-2D1E-460B-B94D-15F509D8B763Q45985707-EDD115EE-1346-4848-9A7F-0E02CAD593BBQ47857273-824492A7-A60D-4DE6-A8FD-BD29E39EF222Q47889160-D6A69DDA-0445-428F-A336-6BC451B32572Q47930525-4F9A71FF-4425-4957-BC35-A4D0EAB98880Q51961303-8C98F394-464C-4DAB-888A-15F00BC53AD5Q54452411-4FDC28FD-5CE2-4E2F-947D-3F36963FD71BQ56983747-AAE74E3D-C8D4-4012-A8CD-85E515887BC0Q57240629-106D1922-0B73-456A-920B-1A5A0D999221Q57240631-AC5E87A8-592E-42EF-8A68-991855BB1272Q57240632-A5399048-EA8E-4AEC-B1BD-DA6E34CFA896Q57240633-3AA8C625-86EB-4104-AEF6-997E140059B1Q57240635-8AE4EED1-0C00-4998-8A5B-18D7FB5CA4F7Q57240638-5DABEE4A-4484-46F2-9EA7-24C55562E4A1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lukasz Kedzierski
@ast
Lukasz Kedzierski
@en
Lukasz Kedzierski
@es
Lukasz Kedzierski
@nl
Lukasz Kedzierski
@sl
type
label
Lukasz Kedzierski
@ast
Lukasz Kedzierski
@en
Lukasz Kedzierski
@es
Lukasz Kedzierski
@nl
Lukasz Kedzierski
@sl
prefLabel
Lukasz Kedzierski
@ast
Lukasz Kedzierski
@en
Lukasz Kedzierski
@es
Lukasz Kedzierski
@nl
Lukasz Kedzierski
@sl
P106
P1153
6602378121
P21
P2798
P31
P496
0000-0003-0203-1057